Trends in Typhoid Fever Vaccines Market Point to Increased Access and Adoption
Trends in Typhoid Fever Vaccines Market Point to Increased Access and Adoption
Blog Article
The Typhoid Fever Vaccines market has seen substantial growth in recent years owing to advancements in vaccine technologies. Typhoid fever is a life-threatening illness caused by Salmonella Typhi bacteria that spreads through contaminated food and water. It is a major health concern in developing countries where access to clean water and proper sanitation is limited. Typhoid vaccines help prevent the disease and reduce its associated societal and economic burden.
Typhoid vaccines are available in injectable and oral forms. The injectable vaccines elicit long-lasting protective antibodies after two to three doses and are widely used for children over two years of age. Oral vaccines consisting of live attenuated strains have unique advantages like administration via a single dose and induction of immunity in the intestinal mucosa, the primary site of Salmonella infection. They do not require trained healthcare workers for administration and are better suited for mass immunization campaigns.
Global typhoid fever vaccines market is estimated to be valued at US$ 351.4 million in 2022 and is expected to exhibit a CAGR of 12.2% during the forecast period (2022-2030).
Key Takeaways
- Key players operating in the typhoid fever vaccines market are GlaxoSmithKline Plc., Sanofi SA, Bharat Biotech, Bio-Med Pvt. Ltd., PT Bio Farma, PaxVax, Inc. Shanghai Institute of Biological Products Co., Ltd., and Prokarium.
- Increasing vaccination programs in developing nations present major growth opportunities in accessible and affordable typhoid vaccines.
- Advancements in live attenuated oral vaccines allow for easier mass administration and induction of immunity at the intestinal site of infection.
Market Drivers
- Rising incidence of drug-resistant typhoid cases has prompted increased immunization efforts by governments and international organizations.
- Growing awareness about the health and economic impact of typhoid is driving higher demand for preventative vaccines in endemic regions.
- WHO recommends vaccination in areas with high disease rates, acting as an endorsement for national vaccination programs.
Challenges in the Typhoid Fever Vaccines Market
The typhoid fever vaccines market is facing various challenges with regards to high production costs involved. Manufacturers have to undergo lengthy and expensive clinical trials to assess vaccine efficacy and safety. rising raw material and labor costs further inflate the vaccine production costs. access and affordability remains a big challenge in developing nations where the disease burden is highest. lack of comprehensive vaccination programs and inadequate healthcare infrastructure in these countries hamper greater uptake of effective typhoid vaccines. Also, increased antibiotic resistance shown by salmonella typhi bacteria poses a critical threat as it reduces treatment effectiveness.
SWOT Analysis
Strength: Effective vaccines like typhoid conjugate vaccine provide long lasting protection against the disease.
Weakness: High costs involved in vaccine production and clinical development make it challenging for greater affordability and accessibility.
Opportunity: Developing nations with major disease prevalence present sizable market potential for vaccine manufacturers and aid organizations.
Threats: Growing antibiotic resistance in salmonella typhi bacteria reduces treatment efficacy and poses apublic health threat.
Geographical Regions
In terms of value, the Asia Pacific region accounts for the major share in the typhoid fever vaccines market. This is mainly due to the high disease burden countries like India, Pakistan and other Southeast Asian countries located in this region. As per WHO estimates, over 11 million cases of typhoid fever occur every year in these developing APAC economies with lack of sanitation and hygiene facilities driving the infection rates.
The market for typhoid fever vaccines is anticipated to witness fastest growth in the Africa region over the forecast period. This is attributed to ongoing vaccination programs being undertaken by global health organizations to curb the rising incidence. Countries like Nigeria, Democratic Republic of Congo and Ethiopia report large number of annual cases, emphasizing the need for strengthening immunization in these resource-limited markets.
Get More Insights on Typhoid Fever Vaccines Market
Get This Report in Japanese Language -溶接機器市場
Get This Report in Korean Language -용접 장비 시장
Read More Articles Related to this Industry -
How Agar is revolutionizing the Pharmaceutical and Biotechnology Sectors
About Author:
Vaagisha brings over three years of expertise as a content editor in the market research domain. Originally a creative writer, she discovered her passion for editing, combining her flair for writing with a meticulous eye for detail. Her ability to craft and refine compelling content makes her an invaluable asset in delivering polished and engaging write-ups.
(LinkedIn: http://www.linkedin.com/in/vaagisha-singh-8080b91)
copyright src="chrome-extension://fpjppnhnpnknbenelmbnidjbolhandnf/content_script_web_accessible/ecp_regular.js" type="text/javascript"> Report this page